Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: J Am Geriatr Soc. 2019 Nov 1;68(2):337–345. doi: 10.1111/jgs.16228

Table 1.

Participant Characteristics by Smoking Status (visit 4, 1996–98), Atherosclerosis Risk in Communities (ARIC) Neurocognitive Studya

Total Cohort (N=13002) Smoking Status P-valueb
Never (N=5784) Former (N=5898) Current (N=1872)
Quit ≥ 9 years ago (N=4235) Quit < 9 years ago (N=1111)
Age (years), mean (SD) 63.0 (5.7) 63.1 (5.7) 63.6 (5.7) 62.9 (5.4) 61.7 (5.4) <0.0001
Black race, N(%) 3304 (25) 1659 (29) 783 (18) 312 (28) 550 (29) <0.0001
Female, N(%) 7427 (57) 4071 (70) 1697 (40) 622 (56) 1037 (55) <0.0001
Education, N(%)
 < High school 2773 (21) 1111 (19) 819 (19) 292 (26) 551 (30) <0.0001
 High school or equivalent 5364 (41) 2440 (42) 1676 (40) 478 (43) 770 (41)
 > High school 4847 (37) 2224 (39) 1736 (41) 340 (31) 547 (29)
BMI (kg/m2) 28.8 (5.9) 29.2 (5.8) 30.0 (5.3) 29.2 (5.6) 27.0 (5.2) <0.0001
Diabetes, N(%) 2111 (19) 945 (19) 718 (19) 204 (23) 244 (17) 0.007
Hypertensive Status, N(%)
 Normotensive 5315 (45) 2391 (44) 1719 (44) 431 (44) 774 (49) <0.0001
 Prehypertension 429 (4) 180 (3) 183 (5) 42 (4) 24 (2)
 Hypertension 6085 (51) 2805 (52) 1987 (51) 509 (52) 784 (50)
COPD, N(%) 928 (9) 294 (6) 303 (8) 123 (14) 208 (15) <0.0001
≥1 APOE ε4 allele 3837 (31) 1686 (30) 1216 (30) 355 (33) 580 (32) 0.081
Follow-up Status, N(%)
 Died during follow-up 2644 (20) 878 (15) 855 (20) 320 (29) 591 (32) <0.0001
 Living, did not attend Visit 5 4492 (35) 2021 (35) 1412 (33) 381 (34) 678 (36)
 Attended Visit 5 5866 (45) 2885 (50) 1968 (46) 410 (37) 603 (32)

Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; APOE, apolipoprotein

a

Restricted to participants with complete covariate data. Analysis includes imputed exposure data: education, N=18; diabetes, N=1892; hypertension, N=1173; APOE ε4, N=435

b

P-values from Kruskal-Wallis test (continuous variables) or Pearson’s chi2 test (categorical variables)